Visit COVID-19 resources

[Skip to Content]

Age-related macular degeneration

Quality Assurance Self Test for AMD Services

Dec 22
2014

20/20 QIPP Quality Assurance Self Test for AMD Services

  • 22 December 2014

Maximising Capacity in AMD Services

Dec 22
2014

Advice for commissioners and service providers on how to maximise capacity in AMD services (June 2013)

  • 22 December 2014

Age-Related Macular Degeneration: Guidelines for Management

Dec 22
2014

College guidelines on the management of AMD

  • 22 December 2014

Choice of anti VEGF agents for wet AMD treatments

Dec 22
2014

College statement on choice of two antiVEGF agents for the treatment of wet AMD, following NICE guidance on Ranibizumab (TA155) and Aflibercept (TA294). March2014

  • 22 December 2014

Commissioning better eye care: Age-related macular degeneration

Dec 22
2014

Clinical commissioning guidance from The College of Optometrists and The Royal College of Ophthalmologists

  • 22 December 2014